Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy ; volume:20 ; number:1 ; day:6 ; month:5 ; year:2022 ; pages:1-10 ; date:12.2022
BMC medicine ; 20, Heft 1 (6.5.2022), 1-10, 12.2022
- Creator
-
Liu, Yue
Xiao, Qian
He, Jinjie
Hu, Hanguang
Du, Jinlin
Zhu, Yuping
Chen, Jiaqi
Liu, Zhuo
Wang, Jianping
Sun, Lifeng
Xu, Dong
Li, Jun
Liao, Xiujun
Wang, Jianwei
Cai, Yibo
Cai, Cheng
Jin, Zhekang
Wang, Liuhong
Yuan, Ying
Ding, Kefeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-022-02357-6
- URN
-
urn:nbn:de:101:1-2022062619313714707900
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Yue
- Xiao, Qian
- He, Jinjie
- Hu, Hanguang
- Du, Jinlin
- Zhu, Yuping
- Chen, Jiaqi
- Liu, Zhuo
- Wang, Jianping
- Sun, Lifeng
- Xu, Dong
- Li, Jun
- Liao, Xiujun
- Wang, Jianwei
- Cai, Yibo
- Cai, Cheng
- Jin, Zhekang
- Wang, Liuhong
- Yuan, Ying
- Ding, Kefeng
- SpringerLink (Online service)